Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DecatSepsis-2: DEX-PRESSIN in Septic Shock
NCT06302998Phase 2Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dexmedetomidine in septic shock, sponsored by Mansoura University. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06302998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06302998.